Hims & Hers Health, Inc. registered 976,341 shares of Class A common stock related to its acquisition of Seaview Enterprises LLC (Medisource) from Nivagen Pharmaceuticals, which closed on September 5, 2024.
AI Assistant
HIMS & HERS HEALTH INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.